Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients

1. González-Martín, A.
2. Fernández, E.
3. Vaz, M.A.
4. Burgos, J.
5. López García, M.
6. Rodríguez Patrón, R.
7. Guillén, C.
8. Mayayo, T.
9. Allona, A.
10. Arias, F.
11. Moyano, A.